TotalMarketCap

Kamada

KMDANasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$397.047 M

$6.88 -7.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Kamada (KMDA) has a market capitalization of $397.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

57,686,056

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #205MapLight TherapeuticsMPLT$402.2M
  2. #206Assembly BiosciencesASMB$401.7M
  3. #207KamadaKMDA$397.0M
  4. #208BlossomHill TherapeuticsBLSM$385.2M
  5. #209AltimmuneALT$382.2M

What if Kamada were worth as much as…

Open the what-if tool →

Gold $28.2T

$489,286.51

Per share 71,117× higher

Bitcoin $1.53T

$26,474.44

Per share 3,848× higher

Apple $5.02T

$86,913.12

Per share 12,633× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Kamada are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.